blog about FDA Implements Mocra Datadriven Risk Assessments for Cosmetic Safety

Have you ever been excited about launching an innovative facial serum, only to hit a roadblock at the crucial stage of product safety substantiation? Market research may predict your cutting-edge, hydrating and anti-aging serum will be a bestseller, but before reaching consumers, it must clear one critical hurdle: proving its safety .

This is the essence of Cosmetic Safety Substantiation. Under the Modernization of Cosmetics Regulation Act (MoCRA), which amends the Federal Food, Drug, and Cosmetic Act (FD&C Act), all cosmetic manufacturers must now fully substantiate product safety before bringing products to market. This isn't just about regulatory compliance—it's fundamental to protecting brand reputation, earning consumer trust, and avoiding potential recalls or litigation.

MoCRA's core requirement mandates that cosmetic manufacturers establish and maintain adequate safety substantiation records for each product before market launch. The regulation (21 USC 364d: Safety substantiation) specifies:

(a) Safety Substantiation: Responsible persons must ensure and maintain records supporting product safety substantiation.

(b) Coal Tar Hair Dyes: This section doesn't apply to coal tar hair dyes that meet section 361(a) requirements, though their responsible persons must still maintain safety-related records.

(c) Definitions:

• Adequate safety substantiation: Testing, studies, analyses, or other evidence sufficient to support that a cosmetic is safe, as evaluated by qualified experts with scientific training and experience.
• Safe: A cosmetic that isn't harmful under labeled or customary conditions of use. Products shouldn't be deemed harmful solely for causing mild, transient reactions in some users. Regulators may consider cumulative exposure when evaluating safety.

In essence, MoCRA requires scientific evidence demonstrating your product won't harm consumers when used as intended. This can't rely on assumptions from similar products—it demands concrete data from existing research, validated testing methods, or comprehensive ingredient safety records.

For example, if your serum contains hyaluronic acid, you might reference safety data from the Cosmetic Ingredient Review (CIR) panel. But for novel botanical extracts, you may need to conduct toxicology studies or specialized testing.

When beginning safety substantiation, several authoritative resources can guide your process:

• FDA Cosmetic Safety Guidelines: Foundational documents for understanding U.S. regulatory requirements.
• ISO Standards: International standards for testing methods and quality control.
• International Organizations: Frameworks like ICCR and ECHA's REACH provide guidance for global market compliance.

The first step is precisely identifying all potentially risky substances in your formula. For each serum ingredient, you'll need:

• INCI Names: Standardized international nomenclature for cosmetic ingredients.
• CAS Numbers: Unique identifiers for chemical substances.

Additionally, analyze each ingredient's physical properties, stability, and solubility. For structurally similar compounds to well-studied substances, you might use "read-across" methods to leverage existing safety data.

Certificates of Analysis (COA) are crucial for verifying purity and absence of contaminants like heavy metals—especially important as multiple U.S. states ban cosmetics containing certain heavy metals.

A systematic literature review is essential. For instance, if your serum contains bergamot oil, research might reveal photosensitivity risks that inform your concentration limits. Resources like CIR monographs and IFRA standards provide valuable guidance.

When existing data is insufficient, consider advanced methods like Threshold of Toxicological Concern (TTC) assessments to evaluate potential risks based on exposure levels.

After compiling ingredient data, conduct toxicity assessments. New Generation Risk Assessment (NGRA) methods are becoming standard, utilizing:

• In vitro testing
• Computer modeling (in silico)

These approaches are both ethical and often more reliable than traditional methods. For example, novel preservatives might undergo in vitro skin irritation testing, while established ones like phenoxyethanol can reference existing carcinogenicity/mutagenicity/reproductive toxicity (CMR) data.

Even safe ingredients require careful exposure evaluation. For your facial serum, consider:

• Dermal Absorption: Leave-on products assume 100% absorption; rinse-off products like cleansers have significantly lower rates.
• Daily Usage: Estimate actual consumer use (e.g., 2g serum per application) to calculate each ingredient's exposure dose (usage amount × concentration).

Special populations (e.g., pregnant women) may require additional exposure scrutiny for certain ingredients.

This core calculation quantifies the ratio between safe exposure levels and actual consumer exposure:

MoS = No Observed Adverse Effect Level (NOAEL) / Systemic Exposure Dose (SED) or Local Exposure Dose (LED)

Higher MoS values indicate greater safety. Typically, MoS ≥ 100 is considered the safety threshold for systemic exposure.

Cosmetic safety compliance isn't a one-time task—it's an ongoing process throughout the product lifecycle. Follow this structured approach:

1. Ingredient Identification: Document all INCI names, CAS numbers, purity, and impurity information.
2. Literature Review: Systematically research existing studies to evaluate potential risks.
3. Toxicity Assessment: Apply NGRA methods for in vitro or computational evaluations.
4. Exposure Assessment: Quantify consumer exposure under normal use conditions.
5. Safety Margin Calculation: Use MoS and other metrics to quantify product safety.

This systematic method ensures compliance with MoCRA while protecting brand reputation and consumer trust in an increasingly regulated global cosmetics market.